A British Biotech Biopedia: Early Days in the U.K.
The rise of British biotech—part of late ’70s and early ’80s culture—should be better documented and made part of our shared history.
Stay updated with breaking news from Simba Gill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The rise of British biotech—part of late ’70s and early ’80s culture—should be better documented and made part of our shared history.
CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new...
Published: Jun 01, 2021 CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021. Mr. Plinio brings significant pharmaceutical sales and marketing leadership to Evelo, including experience building and managing blockbuster brands through all stages of commercialization. “We are pleased to welcome Mark to Evelo as we look forward to key milestones across our br...
Evelo Biosciences Announces Appointment of Mark Plinio as Chief Commercial Officer June 01, 2021 07:00 ET | Source: Evelo Biosciences, Inc. Evelo Biosciences, Inc. Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021. Mr. Plinio brings significant pharmaceutical sales and market...
Evelo Biosciences, Inc.: Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights -Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting- -Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors- -Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets- -Multiple clinical data readouts expected over next 18 months- -Management to host conference ...